PersTIgAN

Guidance predicting therapy response in IgAN is currently lacking although controlled studies have yielded reductions in proteinuria. To serve this urgent need, the project aims at developing an urine-proteomic biomarker-based algorithm that predicts immunosuppressive drug response in IgAN, personalizing intervention and significantly improving patient management.

This project has received funding from the European Union ERA PerMed Joint Transnational Call for Proposal 2018